跳至主要内容
临床试验/JPRN-UMIN000015065
JPRN-UMIN000015065招募中2 期

Evaluation for effects on anticancer efficacy and patient's QOL from dosage adjustment caused by skin toxicity in Panitumumab treatment for Metastatic Colorectal Cancer - Evaluation for effects from dosage adjustment caused by skin toxicity in Panitumumab treatment for metastatic colorectal cancer

Gifu Prefectual Tajimi Hospital0 个研究点目标入组 20 人开始时间: 2014年9月5日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Presence of severe drug allergy 2. Administration contraindication of using drugs 3. Antiplatelet or anticoagulant cannot be discontinued 4. Active infectious disease causing fever more than 38 deg C 5. Active gastrointestinal bleeding 6. Serious comorbidities (ileus, interstitial pneumonia, pulmonary fibrosis, uncontrollable diabetes, severe renal failure and liver failure etc.) 7. Pleural effusion or ascites that drainage is needed for 8. Other active malignancies those DFS is within 5 years (except for carcinoma in situ that was confirmed cured by local treatment) 9. Women of childbearing potential, women in pregnancy or lactation and patients who have desire to bear children 10. Investigator deems inappropriate to participate in the test

研究者

发起方
Gifu Prefectual Tajimi Hospital

相似试验